As a leading pharmaceutical company with over 36 years of experience in development and manufacture of OSDs and liquid preparations, Nepal Pharmaceuticals Laboratory Pvt. Ltd. is specialized in high quality cGMP manufacturing of numerous OSDs and liquid preparations for clinical practice in different therapeutic areas.
NPL is undergoing a transformation unlike any other in its history. New technologies are being developed with the promise of ensuring quality medicines at reduced cost. This could lead us to improved, and possibly affordable therapies in access of every general population. Countless new medicines are in development that will impact hundreds or thousands of lives in the coming years.
Changes are also underway in manufacturing capacities. NPL have recently launched its parenteral segment consisting of about 8-10 new products in the course of this fiscal year. These new products will cover a variety of essential medicines in injectable dosage form from different therapeutic categories like anesthetics, antiemetic, antiepileptics, antifibrinolytics, diuretics, NSAIDs etc. The launching of injectable dosage forms from Nepal Pharmaceuticals Labaratory Pvt. Ltd. once again demonstrates NPL’s strategic focus on expanding access to safe, effective & quality products and services at substantially lower costs.
We provide state-of-the-art tools, technologies and services in field of parenteral dosage form such as:
NPL’s Injectable manufacturing covers both Terminal Sterilization and Aseptic Filling Technologies for Vials, Ampoules with a wide range of filling volumes.
Aseptic injectable operations are split into two manufacturing facilities, depending upon the lifecycle phase of your product and the scale of manufacturing required. Both the Clinical & Commercial Aseptic facilities have been inspected & granted manufacturing license by numerous regulatory agencies.
Our largest injectable filling capacity is represented by the terminal sterilization facility, which is comprised of different filling lines following the classical process of washing / depyrogenation, filling, stoppering, and finally terminal sterilization. The final inspection of your product is conducted on fully-automated systems where possible, although semi-automated and manual inspections are possible where the drug product formulation dictates it.
Currently, we are present in sterile injectables of a variety of essential medicines in injectable dosage form from different therapeutic categories like anesthetics, antiemetic, antiepileptics, antifibrinolytics, diuretics, NSAIDs etc. Our products are currently delivered via liquid vials, ampoules and efforts are underway to augment additional manufacturing capabilities in other injectables.
Our ethos at work is to consistently focus on meeting diverse injectable needs with high-quality products at attractive price points. On this strong plinth of looking ahead, we have successfully launched our injectable segment enabling us to serve millions of people with our all-time motto ‘Quality in the service of millions’. NPL is also planning to come up with other essential and lifesaving injectables in near future as well.
